Postnatal fate of donor mesenchymal stem cells after transamniotic stem cell therapy in a healthy model
Topic overview
Preclinical study tracking donor mesenchymal stem cells after intraamniotic injection in healthy rat fetuses found no detectable cells in neonatal tissues 16 days postnatally, despite confirmed viability at term. Findings support safety profile for clinical translation of transamniotic stem cell therapy.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Postnatal fate of donor mesenchymal stem cells after transamniotic stem cell therapy in a healthy model. GlobalCastMD Medical Library. 2020-03-10. https://library.globalcastmd.com/article/2346
Comments